Pia Eaves | executive |
Terry Rosen | executive |
Jennifer Jarrett | executive |
Robert Goeltz | executive |
Kaveri Pohlman | analyst |
Dimitry Nuyten | executive |
Peter Lawson | analyst |
Jonathan Miller | analyst |
Jason Zemansky | analyst |
Juan Jaen | executive |
Hello, and welcome to Arcus Biosciences First Quarter 2024 Earnings Call. My name is Lydia, and I will be your operator today. [Operator Instructions] I'll now hand you over to Pia Eaves, Vice President of Investor Relations and Strategy.
Hello, everyone, and thank you for joining us on today's conference call to discuss Arcus' First Quarter 2024 Financial Results and Pipeline Updates. I'd like to remind you that on this call, management will make forward-looking statements, including statements about our cash runway and our expected clinical development milestones and time lines.